Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Uhl, B. Zvarova (Barbora.Zvarova@uvm.edu / University of Vermont, C. of Medicine,Burlington, V. , B. Ahlers (Bethany.Ahlers@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , C. Hood (Catrina.Hood@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , B. Deng (Bin.Deng@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , Y. Lam (Ying-Wai.Lam@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , E. Beatman (BeatmanE@NJHealth.org / National Jewish Health,Denver, C. , K. Schweitzer (SchweitzerK@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , I. Petrache (PetracheI@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , D. Weiss (daniel.weiss@uvm.edu / University of Vermont, C. of Medicine,Burlington, V. , D. Wagner (darcy.wagner@med.lu.se / Lund University,Lund). LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics. 4255

Member's Comments

No comment yet.

Related content which might interest you: Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008 Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Mass spectrometry proteomic biomarkers identify acute COPD exacerbations Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Desmosine as a biomarker of elastin degradation in COPD: current status and future directions Source: Eur Respir J 2008; 32: 1146-1157 Year: 2008 Metabolic profiling detects biomarkers of protein degradation in COPD patients Source: Eur Respir J 2012; 40: 345-355 Year: 2012 LSC - 2018 - Laser-capture microdissection, mass spectrometry and immunohistochemistry reveal pathologic alterations in the extracellular matrix of transplanted lungs Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 A liquid chromatography MS/MS metabolomics study of COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Ion mobility spectrometry in lung transplant patients Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Breath analysis by ion mobility spectrometry in COPD and lung cancer patients Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Development of mass spectrometry approaches to quantifying lipid mediators in airway disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Comparison of the measurement of LCI and FRC by the NDD EasyOne ProLAB and mass spectrometry (MS) Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 The value of rapid speciation of nontuberculous mycobacteria (NTM) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry Source: Eur Respir J 2004; 24: Suppl. 48, 213s Year: 2004 Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis Source: Eur Respir J 2013; 41: 1331-1339 Year: 2013 Mass spectrometry methods for biomarker research for chronic lung allograft dysfunction (CLAD) in systems prediction of CLAD (SysCLAD) Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach Source: Eur Respir J 2003; 21: 414-420 Year: 2003 Identification of disease specific biomarkers by exhalomics using Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS) in children with cystic fibrosis Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018